Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 2/20 | 0.77 |
| ▸ | CTSL | P07711 | 1/20 | 0.67 |
| ▸ | CTSS | P25774 | 1/20 | 0.67 |
| ▸ | CTRB1 | P17538 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.56 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.54 |
| ▸ | PPARG | P37231 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | CASP1 | P29466 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3255533 | 1.00 | ATM (0.77) | ATMCTSLCTSSCTRB1ALDH1A1 | |
| SCHEMBL1362502 | 1.00 | ATM (0.77) | ATMCTSLCTSSCTRB1ALDH1A1 | |
| SCHEMBL7719287 | 1.00 | ATM (0.77) | ATMCTSLCTSSCTRB1ALDH1A1 | |
| SCHEMBL5742255 | 0.92 | ATM (0.67) | ATMCTSLCTSSCTRB1ALDH1A1 | |
| SCHEMBL17765000 | 0.92 | ATM (0.67) | ATMCTSLCTSSCTRB1ALDH1A1 | |
| SCHEMBL5742261 | 0.92 | ATM (0.67) | ATMCTSLCTSSCTRB1ALDH1A1 | |
| SCHEMBL11205232 | 0.90 | ATM (0.64) | ATMCTSLCTSSCTRB1LMNA | |
| SCHEMBL28224944 | 0.90 | ATM (0.64) | ATMCTSLCTSSCTRB1ALDH1A1 | |
| SCHEMBL28224943 | 0.90 | ATM (0.64) | ATMCTSLCTSSCTRB1ALDH1A1 | |
| SCHEMBL6736883 | 0.89 | ATM (0.70) | ATMCTSLCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250059171-A1 | ANTIVIRAL COMPOUNDS | HOFFMANN-LA ROCHE INC. (US) | 2025-02-20 | — | — | US | disclosed |
| EP-4444711-A1 | ANTIVIRAL COMPOUNDS | F. Hoffmann-La Roche AG (CH) | 2024-10-16 | — | — | EP | disclosed |
| EP-4425181-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | Bertis Inc (KR) | 2024-09-04 | — | — | EP | disclosed |
| US-20240011979-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS INC. (KR) | 2024-01-11 | — | — | US | disclosed |
| CN-116829949-A | Compositions for detecting or measuring analytes | 伯蒂斯有限公司 | 2023-09-29 | — | — | CN | disclosed |
| US-20230279553-A1 | Method for Manufacturing Conductive Pattern-Provided Structure | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-09-07 | — | — | US | disclosed |
| EP-4234758-A1 | METHOD FOR MANUFACTURING CONDUCTIVE PATTERN-PROVIDED STRUCTURE | Asahi Kasei Kabushiki Kaisha (JP) | 2023-08-30 | — | — | EP | disclosed |
| WO-2023104882-A1 | ANTIVIRAL COMPOUNDS | F. HOFFMANN-LA ROCHE AG (CH) | 2023-06-15 | — | — | WO | disclosed |
| WO-2023078410-A1 | COMPOUND HAVING ACTIVITY OF DEGRADING GSPT1 AND APPLICATION THEREOF | 上海美志医药科技有限公司 | 2023-05-11 | — | — | WO | disclosed |
| WO-2023075435-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | 주식회사 베르티스 | 2023-05-04 | — | — | WO | disclosed |
| EP-1060178-A1 | HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES | PFIZER INC. (US) | 2000-12-20 | — | — | EP | disclosed |
| EP-0998488-A1 | POLYOL-AMINO ACID COMPOUNDS HAVING ANTI-HELICOBACTER PYLORI ACTIVITY | Takeda Chemical Industries, Ltd. (JP) | 2000-05-10 | — | — | EP | disclosed |
| WO-1999045006-A1 | HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES | PFIZER INC. (US) | 1999-09-10 | — | — | WO | disclosed |
| WO-1999002549-A1 | POLYOL-AMINO ACID COMPOUNDS HAVING ANTI-HELICOBACTER PYLORI ACTIVITY | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1999-01-21 | — | — | WO | disclosed |
| EP-0768303-A1 | OPTICALLY ACTIVE QUINOLINECARBOXYLIC ACID DERIVATIVE AND PROCESS FOR PRODUCING THE SAME | NIPPON SHINYAKU COMPANY, LIMITED (JP) | 1997-04-16 | — | — | EP | disclosed |
| WO-1996027370-A1 | FREE RADICAL SCAVENGER MOLECULES | BRITISH TECHNOLOGY GROUP LIMITED (GB) | 1996-09-12 | — | — | WO | disclosed |
| EP-0069894-B1 | OPTICALLY ACTIVE DIPEPTIDES, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | A. Nattermann & Cie. GmbH (DE) | 1985-04-10 | — | — | EP | disclosed |
| US-4505854-A | Optically active dipeptides and the use thereof as tissue dissolving and histolytic agent in human beings | NATTERMANN & CIE GMBH (DE) | 1985-03-19 | — | — | US | disclosed |
| EP-0074837-A1 | 4-Substituted pyridine catalysts | REILLY TAR & CHEMICAL CORPORATION (US) | 1983-03-23 | — | — | EP | disclosed |
| EP-0069894-A1 | Optically active dipeptides, pharmaceutically acceptable salts thereof, process for their preparation and pharmaceutical compositions containing them | A. Nattermann & Cie. GmbH (DE) | 1983-01-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250059171-A1 | ANTIVIRAL COMPOUNDS | ZC3HAV1, ACE, EIF2AK2 | ATM 4706/4885CTSL 100/4885CTSS 95/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.